A detailed history of Quest Partners LLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 6,430 shares of SERA stock, worth $51,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,430
Previous 1,015 533.5%
Holding current value
$51,440
Previous $6.01 Million 734.65%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$5.29 - $8.43 $28,645 - $45,648
5,415 Added 533.5%
6,430 $50.2 Million
Q2 2024

Aug 06, 2024

BUY
$5.6 - $11.69 $5,684 - $11,865
1,015 New
1,015 $6.01 Million

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $237M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.